Gagnon Securities LLC Buys 10,086 Shares of athenahealth, Inc (ATHN)
Gagnon Securities LLC raised its stake in shares of athenahealth, Inc (NASDAQ:ATHN) by 33.7% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 39,992 shares of the health services provider’s stock after purchasing an additional 10,086 shares during the period. athenahealth accounts for about 1.9% of Gagnon Securities LLC’s investment portfolio, making the stock its 22nd biggest holding. Gagnon Securities LLC’s holdings in athenahealth were worth $5,321,000 as of its most recent filing with the SEC.
A number of other large investors also recently added to or reduced their stakes in the business. BlackRock Inc. grew its holdings in athenahealth by 1.4% during the fourth quarter. BlackRock Inc. now owns 1,661,698 shares of the health services provider’s stock valued at $221,073,000 after purchasing an additional 22,767 shares during the period. Allianz Asset Management GmbH grew its holdings in athenahealth by 67.0% during the fourth quarter. Allianz Asset Management GmbH now owns 555,766 shares of the health services provider’s stock valued at $73,939,000 after purchasing an additional 223,006 shares during the period. Jackson Square Partners LLC grew its holdings in athenahealth by 1.1% during the fourth quarter. Jackson Square Partners LLC now owns 531,549 shares of the health services provider’s stock valued at $70,717,000 after purchasing an additional 5,811 shares during the period. Sumitomo Mitsui Asset Management Company LTD grew its holdings in athenahealth by 40.3% during the fourth quarter. Sumitomo Mitsui Asset Management Company LTD now owns 454,160 shares of the health services provider’s stock valued at $60,421,000 after purchasing an additional 130,545 shares during the period. Finally, ARK Investment Management LLC grew its holdings in athenahealth by 55.5% during the fourth quarter. ARK Investment Management LLC now owns 379,439 shares of the health services provider’s stock valued at $50,481,000 after purchasing an additional 135,383 shares during the period.
In other news, Director Jeffrey R. Immelt bought 3,600 shares of the firm’s stock in a transaction that occurred on Tuesday, February 27th. The shares were bought at an average cost of $141.04 per share, for a total transaction of $507,744.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Jonathan Bush sold 4,750 shares of the business’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $141.11, for a total value of $670,272.50. Following the completion of the sale, the chief executive officer now owns 320,557 shares in the company, valued at $45,233,798.27. The disclosure for this sale can be found here. Insiders sold 102,003 shares of company stock worth $13,968,027 over the last quarter. 3.20% of the stock is owned by company insiders.
athenahealth (NASDAQ:ATHN) last posted its earnings results on Thursday, February 1st. The health services provider reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $0.63 by $0.48. The company had revenue of $329.20 million for the quarter, compared to the consensus estimate of $319.64 million. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The firm’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same period in the previous year, the business earned $0.62 earnings per share. analysts anticipate that athenahealth, Inc will post 2.71 EPS for the current fiscal year.
A number of equities analysts have recently weighed in on the company. BidaskClub raised athenahealth from a “sell” rating to a “hold” rating in a research note on Saturday, December 16th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $160.00 price objective on shares of athenahealth in a research note on Friday, February 16th. Canaccord Genuity upped their price objective on athenahealth from $123.00 to $137.00 and gave the stock a “hold” rating in a research note on Thursday, February 1st. Citigroup assumed coverage on athenahealth in a research note on Thursday, January 4th. They issued a “neutral” rating for the company. Finally, Royal Bank of Canada set a $141.00 price objective on athenahealth and gave the stock a “hold” rating in a research note on Thursday, February 15th. Three research analysts have rated the stock with a sell rating, seventeen have given a hold rating and seven have given a buy rating to the stock. athenahealth currently has an average rating of “Hold” and a consensus target price of $144.35.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc (NASDAQ:ATHN).
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.